ScholarIQanswers from OpenAlex & ORCID
Yuanyuan Zhao
ResearcherPublications, citations & collaboration network
Yuanyuan Zhao is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yuanyuan Zhao have?
ScholarIQindexed works
Yuanyuan Zhao has 268 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yuanyuan Zhao have?
ScholarIQcitation count
Yuanyuan Zhao has 6,303 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yuanyuan Zhao?
ScholarIQh-index
Yuanyuan Zhao has an h-index of 42 in OpenAlex.
What is the i10-index of Yuanyuan Zhao?
ScholarIQi10-index
Yuanyuan Zhao has an i10-index of 109 in OpenAlex.
What is the ORCID of Yuanyuan Zhao?
ScholarIQorcid
The ORCID for Yuanyuan Zhao is on the source record.
What is the OpenAlex record for Yuanyuan Zhao?
ScholarIQopenalex
The OpenAlex for Yuanyuan Zhao is on the source record.
What are the most-cited papers on Yuanyuan Zhao?
ScholarIQmost cited works
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
Wenfeng Fang, Yunpeng Yang, Yuxiang Ma, Shaodong Hong, Lizhu Lin, Xiaohui He, Jianping Xiong, Ping Li, Hongyun Zhao, Yan Huang, Yang Zhang, Likun Chen, Ningning Zhou, Yuanyuan Zhao, Xue Hou, Qing Yang, Li Zhang
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
Wenfeng Fang, Jianwei Zhang, Shaodong Hong, Jianhua Zhan, Nan Chen, Tao Qin, Yanna Tang, Yaxiong Zhang, Shiyang Kang, Ting Zhou, Xuan Wu, Wenhua Liang, Zhihuang Hu, Yuxiang Ma, Yuanyuan Zhao, Ying Tian, Yunpeng Yang, Cong Xue, Yue Yan, Xue Hou, Pei-Yu Huang, Yan Huang, Hongyun Zhao, Li Zhang
Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
Li Zhang, Kenzie D. MacIsaac, Ting Zhou, Pei‐Yu Huang, Chunlin Xin, Jason R. Dobson, Kun Yu, Derek Y. Chiang, Yue Fan, Marc R. Pelletier, Yan Wang, Savina Jaeger, Viveksagar Krishnamurthy Radhakrishnan, Lellean JeBailey, Peter Skewes-Cox, Jing Zhang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Yuanyuan Zhao, En Li, Bin Peng, Alan Huang, Glenn Dranoff, Peter S. Hammerman, Jeffrey A. Engelman, Hans Bitter, Yi‐Xin Zeng, Yao Yao
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)
Yunpeng Yang, Jianji Pan, Hui Wang, Yuanyuan Zhao, Shenhong Qu, Nianyong Chen, Xiaozhong Chen, Yan Sun, Xiaohui He, Chaosu Hu, Lizhu Lin, Qitao Yu, Siyang Wang, Guihua Wang, Feng Lei, Jiyu Wen, Kunyu Yang, Zhixiong Lin, Ye Guo, Shaoqing Chen, Xiaoming Huang, Yanjie Wu, Liang Liang, Chenqi Chen, Fan Bai, Xiaopeng Ma, Yun Zhang, Shiangjiin Leaw, Li Zhang, Wenfeng Fang
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With <i>EGFR</i> Variant
HARMONi-A Study Investigators, Wen‐Feng Fang, Yuanyuan Zhao, Yongzhong Luo, Runxiang Yang, Yan Huang, Zhiyong He, Hui Zhao, Mingjun Li, Kai Li, Qibin Song, Xiaobo Du, Yulan Sun, Wei Li, Fei Xu, Zhiyu Wang, Kunning Yang, Yun Fan, Baogang Liu, Hongyun Zhao, Ying Hu, Lee Jia, Xu Shen, Tienan Yi, Dongqing Lv, Haitao Lan, Mengxia Li, Wenhua Liang, Yongsheng Wang, Hui Yang, Yuming Jia, Yuan Chen, Jun‐Guo Lu, Jifeng Feng, Chunling Liu, Ming Zhou, Jianya Zhou, Xianling Liu, Ningning Zhou, Ming He, Xiaorong Dong, Hualin Chen, Yongxing Chen, Haichuan Su, Xiaoling Li, Zhihong Zhang, Lei Yang, Ying Cheng, Likun Chen, Xue Hou, Yu Zhang, Jun Guo, Zhen Wang, Hong Lu, Di Wu, Weineng Feng, Wen Li, Jian‐An Huang, Yan Wang, Xia Song, Jiewen Peng, Laiyu Liu, Yubiao Guo, Wenting Li, Dongmei Lu, Mingxiu Hu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Li Zhang